Hae-Jin Kim

24PUBLICATIONS
74CO-AUTHORS
Traditional Chinese medicine and treatmentsPharmacogenomicsNutritional epidemiologyMetabolic medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 25, 2026
Highlights of the 2026 Korean Society of Hypertension guidelines for the management of hypertension: what's new and what has changed.

|Dec 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial.

Seung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong

|Oct 15, 2025
Is the next STEP on the BPROAD to intensive blood pressure lowering for all type 2 diabetic patients?: consensus statements from the Korean Society of Hypertension.

Eun Mi Lee, In-Jeong Cho, Hae Jin Kim

|May 14, 2025
Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yu Jung Heo, Jieun Park, Nami Lee

|Jul 31, 2024
Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells.

Yu Jung Heo, Jieun Park, Nami Lee

|Jan 15, 2024
A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study).

Hae Jin Kim, Jung Hyun Noh, Min Kyong Moon

Pageof 4

Frequent Collaborators

7 joint publications

Dae-Jung Kim

7 joint publications

Seung-Jin Han

5 joint publications

Kwan-Woo Lee

5 joint publications

In-Kyung Jeong